Artemis Medicare Services Ltd
NSE: ARTEMISMED BSE: 542919Healthcare
Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1][2]
₹274
52W: ₹203 — ₹298
PE 41 · Book ₹59.3 · +362% vs bookMarket Cap₹4,337 Cr
Stock P/E41Price to Earnings
ROCE14.5%Return on Capital
ROE11.9%Return on Equity
Div. Yield0.16%Face Value ₹1
Strengths
- +Company has delivered good profit growth of 75.6% CAGR over last 5 years
Weaknesses
- −Stock is trading at 4.64 times its book value
- −Company has a low return on equity of 12.1% over last 3 years.
- −Promoter holding has decreased over last 3 years: -10.5%
Shareholding Pattern
Promoters58.39%
FIIs12.19%
DIIs2.89%
Public20.37%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 67.51% | 67.17%▼0.3 | 67.17% | 67.17% | 66.53%▼0.6 | 66.53% | 58.38%▼8.1 | 58.39%▲0.0 |
| FIIs | 0.16% | 0.21%▲0.0 | 0.65%▲0.4 | 0.31%▼0.3 | 0.24%▼0.1 | 0.37%▲0.1 | 12.47%▲12.1 | 12.19%▼0.3 |
| DIIs | 3.45% | 3.6%▲0.1 | 4.51%▲0.9 | 5.04%▲0.5 | 4.76%▼0.3 | 4.27%▼0.5 | 2.91%▼1.4 | 2.89%▼0.0 |
| Public | 21.76% | 21.93%▲0.2 | 20.59%▼1.3 | 20.39%▼0.2 | 21.45%▲1.1 | 21.81%▲0.4 | 20.07%▼1.7 | 20.37%▲0.3 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 210 | 217 | 217 | 235 | 227 | 235 | 250 | 270 | 267 | 274 |
| Expenses | 179 | 181 | 181 | 193 | 190 | 199 | 209 | 220 | 223 | 224 |
| Operating Profit | 32 | 36 | 36 | 42 | 37 | 36 | 41 | 50 | 44 | 50 |
| OPM % | 15% | 17% | 16% | 18% | 16% | 15% | 16% | 19% | 16% | 18% |
| Net Profit | 12 | 14 | 17 | 23 | 21 | 23 | 21 | 30 | 23 | 30 |
| EPS ₹ | 0.85 | 1.02 | 1.24 | 1.64 | 1.51 | 1.69 | 1.54 | 2.16 | 1.42 | 1.87 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹1,060Cr, up 16.1% YoY. OPM at 17%.
Debt Position
Borrowings at ₹260Cr. Debt-to-equity ratio: 0.28x. Healthy balance sheet.
Capex Cycle
CWIP at ₹32Cr (4% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 2.89% (+1.48pp change). FIIs: 12.19% (+12.12pp change). Promoters hold 58.39%.
Margin & Efficiency
ROCE improving from 14% (Mar 2015) to 15% (Mar 2026). Working capital days: -19.
Valuation
PE 41x with 14.5% ROCE. Price is 362% above book value of ₹59.3. Dividend yield: 0.16%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 2d - Q4/FY26 transcript: revenue up 15.4% to INR 1,081 crore; PAT up 26.2%; Raipur starts Q1 FY27.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 2d - Newspaper Publication for opening of the special window for transfer and dematerialisation of physical securities
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 11 May - Audio recording of Q4 and FY26 earnings conference call available on May 11, 2026.
- Announcement under Regulation 30 (LODR)-Change in Directorate 10 May - Mr. Sunil Tandon ceased as Independent Director on May 9, 2026.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 9 May
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse